Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Hospira 3Q09 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Hospira 3Q09

In the quarter, Global Specialty Injectables revenue was $575.7 million (+24%).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Hospira 3Q09

3Q Revenues: $1.0 billion (+9%)

3Q Earnings: $116.2 million (+42%)

YTD Revenues: $2.8 billion (+4%)

YTD Earnings: $307.2 million (+42%)

Comments: In the quarter, Global Specialty Injectables revenue was $575.7 million (+24%). In the Americas, sales were $449.1 million (+32%). Asia Pacific sales were flat at $57.0 million. Revenue for Other Pharma (including contract manufacturing) was down 2% to $126.0 million in 3Q09. Global Specialty Injectables revenue YTD was $1.5 billion (+10%), with the Americas accounting for $1.2 billion (+17%) and Asia Pacific, $149.0 million (+4%).

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics